266 related articles for article (PubMed ID: 21631241)
21. Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.
Händel EM; Gellhaus K; Khan K; Bednarski C; Cornu TI; Müller-Lerch F; Kotin RM; Heilbronn R; Cathomen T
Hum Gene Ther; 2012 Mar; 23(3):321-9. PubMed ID: 21980922
[TBL] [Abstract][Full Text] [Related]
22. Targeted manipulation of mammalian genomes using designed zinc finger nucleases.
Kandavelou K; Ramalingam S; London V; Mani M; Wu J; Alexeev V; Civin CI; Chandrasegaran S
Biochem Biophys Res Commun; 2009 Oct; 388(1):56-61. PubMed ID: 19635463
[TBL] [Abstract][Full Text] [Related]
23. Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases.
Ramalingam S; London V; Kandavelou K; Cebotaru L; Guggino W; Civin C; Chandrasegaran S
Stem Cells Dev; 2013 Feb; 22(4):595-610. PubMed ID: 22931452
[TBL] [Abstract][Full Text] [Related]
24. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.
Maier DA; Brennan AL; Jiang S; Binder-Scholl GK; Lee G; Plesa G; Zheng Z; Cotte J; Carpenito C; Wood T; Spratt SK; Ando D; Gregory P; Holmes MC; Perez EE; Riley JL; Carroll RG; June CH; Levine BL
Hum Gene Ther; 2013 Mar; 24(3):245-58. PubMed ID: 23360514
[TBL] [Abstract][Full Text] [Related]
25. Quantifying on- and off-target genome editing.
Hendel A; Fine EJ; Bao G; Porteus MH
Trends Biotechnol; 2015 Feb; 33(2):132-40. PubMed ID: 25595557
[TBL] [Abstract][Full Text] [Related]
26. Corporate profile: Sangamo BioSciences, Inc.
Wolffe E
Regen Med; 2016 Jun; 11(4):375-9. PubMed ID: 27226083
[TBL] [Abstract][Full Text] [Related]
27. Genetic correction using engineered nucleases for gene therapy applications.
Li HL; Nakano T; Hotta A
Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
[TBL] [Abstract][Full Text] [Related]
28. Genome engineering with zinc-finger nucleases.
Carroll D
Genetics; 2011 Aug; 188(4):773-82. PubMed ID: 21828278
[TBL] [Abstract][Full Text] [Related]
29. Concise review: putting a finger on stem cell biology: zinc finger nuclease-driven targeted genetic editing in human pluripotent stem cells.
Collin J; Lako M
Stem Cells; 2011 Jul; 29(7):1021-33. PubMed ID: 21544904
[TBL] [Abstract][Full Text] [Related]
30. Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy.
Wayengera M
Theor Biol Med Model; 2011 Jul; 8():26. PubMed ID: 21781315
[TBL] [Abstract][Full Text] [Related]
31. Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
Yao Y; Nashun B; Zhou T; Qin L; Qin L; Zhao S; Xu J; Esteban MA; Chen X
Hum Gene Ther; 2012 Feb; 23(2):238-42. PubMed ID: 21981760
[TBL] [Abstract][Full Text] [Related]
32. Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.
Wilen CB; Wang J; Tilton JC; Miller JC; Kim KA; Rebar EJ; Sherrill-Mix SA; Patro SC; Secreto AJ; Jordan AP; Lee G; Kahn J; Aye PP; Bunnell BA; Lackner AA; Hoxie JA; Danet-Desnoyers GA; Bushman FD; Riley JL; Gregory PD; June CH; Holmes MC; Doms RW
PLoS Pathog; 2011 Apr; 7(4):e1002020. PubMed ID: 21533216
[TBL] [Abstract][Full Text] [Related]
33. Targeted genome editing tools for disease modeling and gene therapy.
Cai M; Yang Y
Curr Gene Ther; 2014 Feb; 14(1):2-9. PubMed ID: 24665839
[TBL] [Abstract][Full Text] [Related]
34. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases.
Chen F; Pruett-Miller SM; Huang Y; Gjoka M; Duda K; Taunton J; Collingwood TN; Frodin M; Davis GD
Nat Methods; 2011 Jul; 8(9):753-5. PubMed ID: 21765410
[TBL] [Abstract][Full Text] [Related]
35. Zinc finger endonuclease targeting PSIP1 inhibits HIV-1 integration.
Badia R; Pauls E; Riveira-Munoz E; Clotet B; Esté JA; Ballana E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4318-27. PubMed ID: 24820090
[TBL] [Abstract][Full Text] [Related]
36. Genome editing with engineered zinc finger nucleases.
Urnov FD; Rebar EJ; Holmes MC; Zhang HS; Gregory PD
Nat Rev Genet; 2010 Sep; 11(9):636-46. PubMed ID: 20717154
[TBL] [Abstract][Full Text] [Related]
37. Creating designed zinc-finger nucleases with minimal cytotoxicity.
Ramalingam S; Kandavelou K; Rajenderan R; Chandrasegaran S
J Mol Biol; 2011 Jan; 405(3):630-41. PubMed ID: 21094162
[TBL] [Abstract][Full Text] [Related]
38. Delivery technologies for genome editing.
Yin H; Kauffman KJ; Anderson DG
Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
[TBL] [Abstract][Full Text] [Related]
39. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
Lai Y
Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
[TBL] [Abstract][Full Text] [Related]
40. Editing CCR5: a novel approach to HIV gene therapy.
Cornu TI; Mussolino C; Bloom K; Cathomen T
Adv Exp Med Biol; 2015; 848():117-30. PubMed ID: 25757618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
